Contrast
June 30, 2026
Expanding MRI Options for Patients and Imaging Programs June 30, 2026
FDA approval of AMBELVIST (gadoquatrane) strengthens Bayer’s connected MR portfolio for imaging programs today and into the future.
Interventional Radiology
June 29, 2026
Interventional Radiology’s Practice Evolution June 29, 2026
Interventional radiology procedures are being concentrated among fewer radiologists, perhaps reflecting recent changes in medical training.
Breast Imaging
June 25, 2026
AI Risk Prediction’s Long-Term Value June 25, 2026
AI-based calculations of breast cancer risk derived from screening mammograms can track cancer risk as it evolves over time.